Therapeutic vaccination with mRNA vaccine encoding shared neoantigens + anti-PD1 limited tumor growth in both the CT26 and 4T1 MMRd orthotopic and subcutaneous models (Figure 3 B, Extended Figure 2), compared to untreated and anti-PD-1 only treated mice. This evidence concerns the gene PDCD1 and neoplasm.